Actively Recruiting

Phase Not Applicable
Age: 45Years - 65Years
FEMALE
NCT03506594

Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Led by Centro de Atenção ao Assoalho Pélvico · Updated on 2024-05-29

58

Participants Needed

1

Research Sites

428 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is conducted in women at the menopause with a clinical diagnosis of Genitourinary Syndrome, which presents symptoms in of vulvovaginal atrophy and tract urinary and were treated with radiofrequency non ablative technique for capacitive transfer in intra-vaginal. All participants were evaluated by a physical therapist and did the exam of PH vaginal, cell maturation index and questionnaires. The participants made five sessions of Radio Frequency (RF) with an interval of seven days between them. The application of RF was performed by physical therapist trained in the technique of radio frequency through the Capenergie brand device with capacitive transfer method using non-ablative handle with active electrode intra-vaginal and coupling electrode placed on the participant's back. For application, the participants were in gynecological position. The session had an average duration above 20 minutes. The temperature was measured by an infrared thermometer when it reached 41graus radiofrequency was maintained for 2 minutes in the anterior wall and 2 minutes more in the posterior wall of vagina.

CONDITIONS

Official Title

Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Who Can Participate

Age: 45Years - 65Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women in menopause up to 65 years old with clinical complaints of Genitourinary Syndrome of Menopause
  • Willing to voluntarily participate in the research
Not Eligible

You will not qualify if you...

  • Limited understanding
  • Neurological degenerative chronic diseases
  • Sensory deficit in the genital region
  • Use of pacemaker
  • Use of copper intrauterine device
  • Women on hormone therapy within the past six months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centro de Atenção ao Assoalho Pelvico

Salvador, Estado de Bahia, Brazil, 40.290-000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here